Partnerships Between Academic Psychiatry and the Pharmaceutical Industry

1. Singh B. Copolov D. Grainger D. Goh J . Partnerships between academic psychiatry and the pharmaceutical industry. The Lilly MAP Initiative. Australasian Psychia try 2004; 12: 220–224.

2. Emanuel E. J. Wendler D. Grady C . What makes clini cal research ethical?. Journal of the American Medical Association 2000; 283: 2701–2711.

3. Dana J. Loewenstein G . A social science perspective on gifts to physicians from industry. Journal of the American Medical Association 2003; 290: 252–255.

4. Katz D. Caplan A. L. Merz J. F . All gifts large and small: toward an understanding of theethics of pharmaceutical industry. gift-giving. American Journal of Bioethics 2003; 3: 39–46.

5. Malhi G . Comment. Australasian Psychiatry 2004; 12: 225–226.

6. Financial disclosure for review authors . Nature Neuroscience 2003; 6: 997.

7. Carroll B. J. Bubin B. T . Editorial policies on financial disclosure. Nature Neuroscience 2003; 6: 999–1000.

8. Lexchin J. Bero L. A. Djulbegovic B. Clark O. . Phar maceutical industry sponsorship and research outcome and quality: systematic review. British Medical Journal 2003; 326: 1167–1170.

9. Melander H. Ahlqvist-Bastad J. Meijer G. Beerman B . Evidence based medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 2003; 326: 1171–1173.

10. Bhandari M. Busse J. W. Jackowski D. . Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Canadian Medical Association Journal 2004; 170: 477–480.

11. Wazana A . Physicians and the pharmaceutical industry: is a gift ever just a gift?. Journal of the American Medical Association 2000; 283: 373–380.

12. Relman A. S. Angell M . America's other drug problem: how the drug industry distorts medicine and politics. New Republic mi, 2002; 227: 27–41.

13. Lilly Melbourne Academic Psychiatry . Department of Psychiatry, University of Mel bourne, Melbourne, http://www.psychiatry.unimelb.edu.au/lillymap/Pages/Lilly%20MAP%20overview.htm .

14. Hicks D. Hamilton K. . Does university-industry col laboration adversely affect university research?. Is sues in Science and Technology 1999; 74–75, www.issues.org/15.4/realnumbers.htm .

15. Access Economics . Exceptional Returns: the Value of Investing in Health R&D in Australia. Australian Society for Medical Research, Canberra 2003, www.asmr.org.au/general/Except.pdf .

16. Singh B . Academic departments of psychiatry in Aus tralia: a need for reinvention. Australasian Psychiatry 2002; 10: 147–154.

17. DiMasi J. A. Hansen B. W. Grabowski H. G . The price of innovation: new estimates of drug development costs. Journal of Health Economics 2003; 22: 151–185.